Globally, billions of people are at risk of malaria, with people living in sub-Saharan Africa at highest risk. Children under five and pregnant women are the most severely affected. Fortunately, malaria is an entirely preventable and treatable disease, and increased malaria control measures are dramatically reducing the malaria burden in many places.

Strategic Approach
MCHIP was a key contributor to the Roll Back Malaria (RBM) partnership, which aims to reduce the global burden of malaria morbidity and mortality. The Program was also a key supporter of the President’s Malaria Initiative (PMI) goal of reducing malaria deaths by half in target countries by reaching 85% of the most vulnerable groups (children under five and pregnant women) with proven and effective malaria prevention and treatment measures. The Program applied successful approaches and innovative practices to address malaria prevention and control comprehensively. MCHIP’s strategy was woman-centered, recognizing that women are the primary care takers of children under five, and was integrated appropriately within maternal and child health as well as HIV programming.

MCHIP supported Ministries of Health in 20 African countries, contributing to increased coverage with proven and effective malaria prevention and treatment measures. These measures included: intermittent preventive treatment for pregnant women (IPTp); distribution and use of long-lasting insecticide treated bed nets (LLINs); indoor residual spraying (IRS); introduction and scale up of both rapid diagnostic tests (RDTs); and artemisinin combination therapies (ACTs).

Achieving goals for malaria, including universal coverage and elimination of the disease, required addressing the health system holistically at the country level, and enabling the global dialogue to advance evidence-based policies and successful approaches. MCHIP built national and local (community, nongovernmental organization [NGO], and facility) capacities and strengthened health systems to accelerate scale-up for prevention and treatment programs addressing MIP and integrated community case management (iCCM) in children under five. The Program provided countries with holistic support to addresses malaria across the health continuum of care—from household to community to facility and, finally, at the policy level.

Specifically, MCHIP :

  • Conducted systematic assessments of MIP and iCCM programs to advance program learning;
  • Strengthened MIP and iCCM services in the context of health systems strengthening; and
  • Promoted MIP and iCCM policies and best practices across countries.

Key Contributions